ACS Webinar focuses on innovative computational methods in drug discovery
WASHINGTON, March 11, 2010 — News media and others interested in the chemical sciences are invited to join the next in a series of American Chemical Society (ACS) Webinars, focusing on Professional Growth and Development.
Scheduled for Thursday, March 18, 2 – 3 p.m. Eastern Time, the free webinar will feature Woody Sherman, Vice President of Applications Science at Schrödinger Inc., speaking on “Staying ahead of the game: Recent innovations in computational methods for drug discovery.”
The ACS Webinars connect you with subject experts and global thought leaders in chemical sciences, management, and business to addresses current topics of interest to scientific and engineering professionals. Each webinar includes a short presentation followed by a Q & A session.
News media and scientists can tune into the conference without charge, but must register in advance.
Sherman’s topics will include:
- How recent innovations in computational methods can impact your projects?
- When should you use (and not use) molecular modeling in your projects?
- What can you learn from past successes in computer-aided drug design?
- Guidance on getting where you want faster; avoiding costly mistakes
Sherman is Vice President of Applications Science at Schrödinger Inc. He received a Ph.D. from MIT, where he developed a novel method for optimizing ligand-binding specificity across a panel of targets and helped develop a novel method to enhance antibody affinity that resulted in a patent. Sherman has authored papers on induced-fit docking, binding specificity, antibody design, fragment docking, and hybrid ligand/structure-based methods. He is a reviewer for many top journals related to computational chemistry and drug design and is on the Editorial Board of Chemical Biology & Drug Design.